NAQC Publishes 2014 Update to Medications Quality Improvement Initiative Issue Paper!
Integration of Tobacco Cessation Medications in State and Provincial Quitlines: A Review of the Evidence and the Practice with Recommendations (2014 Update)
The purpose of this NAQC Quality Improvement Initiative Issue Paper is to provide an update on the comprehensive review of the literature and practice related to the integration of tobacco cessation medications and quitline services that reflects additions to the evidence base and improvements in practice since the first publication (2009). The author discusses the major factors that must be considered in deciding if medications should be offered as part of quitline services, including topics such as cost-effectiveness analysis, choice of medication, determination of quantity of medication to provide and the method of distribution of medications that will be used. A new section on e-cigarettes appears in the update, as well as new content related to concurrent use of more than one type of tobacco to reflect the FDA’s new warning label regulations. Updated recommendations on key issues related to integration of medications into quitline services are provided by the author.
Please find the new paper located on the Issue Paper
page and make sure to join us for the upcoming webinar on June 26
, where the issue paper’s author, Ken Wassum, reviews the update and its recommendations to quitlines and two states share their experiences offering medications via their quitline.